Merck wins FDA approval for subcutaneous Keytruda (MRK:NYSE) Seeking Alpha FDA OKs New Keytruda Shot for Cancer The New York Times EMA committee recommends approval for injectable version of Merck’s Keytruda Reuters Merck wins approval of subcutaneous Keytruda, in bid to extend life of world’s top-selling drug Endpoints News FDA Approves Subcutaneous Pembrolizumab for Solid Tumors OncLive Source link
Read More »